Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
HFE C282Y mutation as a genetic modifier influencing disease susceptibility for chronic myeloproliferative disease.
Andrikovics H, Meggyesi N, Szilvasi A, Tamaska J, Halm G, Lueff S, Nahajevszky S, Egyed M, Varkonyi J, Mikala G, Sipos A, Kalasz L, Masszi T, Tordai A. Andrikovics H, et al. Among authors: halm g. Cancer Epidemiol Biomarkers Prev. 2009 Mar;18(3):929-34. doi: 10.1158/1055-9965.EPI-08-0359. Epub 2009 Mar 3. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19258483
Co-occurrence of Myeloproliferative Neoplasms and Solid Tumors Is Attributed to a Synergism Between Cytoreductive Therapy and the Common TERT Polymorphism rs2736100.
Krahling T, Balassa K, Kiss KP, Bors A, Batai A, Halm G, Egyed M, Fekete S, Remenyi P, Masszi T, Tordai A, Andrikovics H. Krahling T, et al. Among authors: halm g. Cancer Epidemiol Biomarkers Prev. 2016 Jan;25(1):98-104. doi: 10.1158/1055-9965.EPI-15-0805. Epub 2015 Oct 20. Cancer Epidemiol Biomarkers Prev. 2016. PMID: 26487696
Additional chromosome abnormalities, BCR-ABL tyrosine kinase domain mutations and clinical outcome in Hungarian tyrosine kinase inhibitor-resistant chronic myelogenous leukemia patients.
Meggyesi N, Kozma A, Halm G, Nahajevszky S, Bátai A, Fekete S, Barta A, Ujj G, Lueff S, Sipos A, Adám E, Bors A, Reményi P, Masszi T, Tordai A, Andrikovics H. Meggyesi N, et al. Among authors: halm g. Acta Haematol. 2012;127(1):34-42. doi: 10.1159/000331472. Epub 2011 Oct 14. Acta Haematol. 2012. PMID: 22005133
JAK2 46/1 haplotype analysis in myeloproliferative neoplasms and acute myeloid leukemia.
Andrikovics H, Nahajevszky S, Koszarska M, Meggyesi N, Bors A, Halm G, Lueff S, Lovas N, Matrai Z, Csomor J, Rasonyi R, Egyed M, Varkonyi J, Mikala G, Sipos A, Kozma A, Adam E, Fekete S, Masszi T, Tordai A. Andrikovics H, et al. Among authors: halm g. Leukemia. 2010 Oct;24(10):1809-13. doi: 10.1038/leu.2010.172. Epub 2010 Sep 2. Leukemia. 2010. PMID: 20811399 No abstract available.
Lipoprotein Lipase as a Prognostic Marker in Chronic Lymphocytic Leukemia.
Mátrai Z, Andrikovics H, Szilvási A, Bors A, Kozma A, Ádám E, Halm G, Karászi É, Tordai A, Masszi T. Mátrai Z, et al. Among authors: halm g. Pathol Oncol Res. 2017 Jan;23(1):165-171. doi: 10.1007/s12253-016-0132-z. Epub 2016 Oct 18. Pathol Oncol Res. 2017. PMID: 27757836 Free article.
15 results